Tisi, Maria Chiara
 Distribuzione geografica
Continente #
EU - Europa 1.261
NA - Nord America 1.249
AS - Asia 290
AF - Africa 9
SA - Sud America 5
OC - Oceania 2
Totale 2.816
Nazione #
US - Stati Uniti d'America 1.245
DE - Germania 541
CN - Cina 218
SE - Svezia 159
PL - Polonia 158
IT - Italia 118
GB - Regno Unito 75
UA - Ucraina 70
FR - Francia 61
IN - India 40
IE - Irlanda 38
FI - Finlandia 17
TR - Turchia 13
BE - Belgio 8
CI - Costa d'Avorio 7
IR - Iran 6
RU - Federazione Russa 5
CA - Canada 4
CH - Svizzera 3
JP - Giappone 3
VN - Vietnam 3
BR - Brasile 2
EC - Ecuador 2
ES - Italia 2
MY - Malesia 2
NL - Olanda 2
SG - Singapore 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GR - Grecia 1
ID - Indonesia 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 2.816
Città #
Chandler 250
Warsaw 158
Ashburn 106
Fairfield 80
Jacksonville 67
Ann Arbor 65
Nanjing 56
Nürnberg 48
Woodbridge 48
Dearborn 47
San Mateo 41
Beijing 39
Dublin 38
Wilmington 37
Houston 35
Seattle 33
New York 31
Cattolica 30
Milan 20
Bremen 17
Nanchang 17
Boston 15
Kunming 15
Lancaster 15
Lawrence 14
Rome 14
Cambridge 13
Marseille 13
Redmond 12
Munich 11
Redwood City 11
Fremont 10
Hefei 10
Princeton 10
Chicago 8
Izmir 8
Jiaxing 8
Abidjan 7
Brussels 7
Hangzhou 7
Norwalk 7
Tianjin 7
Boardman 6
Changsha 6
Guangzhou 6
London 6
Shenyang 6
Alghero 5
Auburn Hills 5
Chengdu 5
Hebei 5
Jinan 5
Los Angeles 5
Shanghai 5
University Park 5
Zhengzhou 5
Kocaeli 4
Leawood 4
Romainville 4
San Jose 4
Andover 3
Augusta 3
Berlin 3
Lanzhou 3
Mumbai 3
Pune 3
San Diego 3
Ardabil 2
Ben Arous 2
Costa Mesa 2
Dong Ket 2
Gurgaon 2
Helsinki 2
Hyderabad 2
Kish 2
Logvinov 2
Madrid 2
Mountain View 2
Phoenix 2
Quito 2
Radolfzell 2
Sacramento 2
Saronno 2
Xian 2
Amsterdam 1
Auckland 1
Balikesir 1
Bologna 1
Brescia 1
Busto Arsizio 1
Büdelsdorf 1
Campobasso 1
Capannori 1
Castelverde 1
Castrolibero 1
Changchun 1
Chelny 1
Chiswick 1
Denver 1
Dubai 1
Totale 1.647
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 344
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 277
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 257
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 222
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 201
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 174
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 159
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 122
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 101
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 93
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 88
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 88
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 85
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 81
Small lymphocytic lymphoma in a patient with Fabry disease 79
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 72
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) 71
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 67
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 59
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 58
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 47
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 46
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study 43
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report 29
Totale 2.863
Categoria #
all - tutte 7.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019119 0 0 0 0 0 0 0 0 0 30 56 33
2019/2020688 86 89 57 70 52 65 57 34 52 51 51 24
2020/2021291 14 33 22 17 37 16 22 3 30 31 50 16
2021/2022283 40 26 5 5 25 5 12 43 14 17 41 50
2022/2023604 72 83 45 120 28 84 28 51 73 5 9 6
2023/2024184 11 81 4 5 9 43 2 28 1 0 0 0
Totale 2.863